Substantial increases of three TGFβ isoforms (TGFβ1–3) following IR of MC38 or PDA tumors in WT mice are in line with previous reports by others, who showed that TGFβ blockade improves the efficacy of RT in preclinical models and clinical settings35,43. The gene discussed is TGFB1; the disease is Patent ductus arteriosus.